Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BioNTech SE
  6. News
  7. Summary
    BNTX   US09075V1026

BIONTECH SE

(BNTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Pfizer, BioNTech Get US FDA Panel's Endorsement for COVID-19 Vaccine in Children 5 and Up

10/26/2021 | 11:09pm EST


© MT Newswires 2021
All news about BIONTECH SE
12:23pUS Indices Turn Mixed While Treasuries Drop Ahead of Eagerly Awaited November Inflation..
MT
12:09pPfizer, BioNTech Say Booster Vaccine Shot Offers Protection Against Omicron Variant of ..
MT
12:00pPfizer says COVID booster offers protection against omicron
AQ
11:49aGLOBAL MARKETS LIVE : Airbus, BP, Merck, Pfizer, Meta...
11:18aBIONTECH : Jefferies remains Neutral
MD
11:07aEuropean ADRs Nudge Higher in Wednesday Trading
MT
09:58aWALL STREET STOCK EXCHANGE : Uncertain prospects for the year ahead
09:25aWall Street Sees Cautiously Higher Open as Positive Pfizer Vaccine News Eases Omicron F..
MT
08:46aMarketScreener's World Press Review - December 8, 2021
08:37aPfizer says COVID-19 vaccine booster shot ramps up protection against Omicron
AQ
More news
Analyst Recommendations on BIONTECH SE
More recommendations
Financials
Sales 2021 17 474 M 19 788 M 19 788 M
Net income 2021 9 220 M 10 441 M 10 441 M
Net cash 2021 9 793 M 11 090 M 11 090 M
P/E ratio 2021 7,31x
Yield 2021 -
Capitalization 64 868 M 73 106 M 73 456 M
EV / Sales 2021 3,15x
EV / Sales 2022 2,63x
Nbr of Employees 2 800
Free-Float 87,3%
Chart BIONTECH SE
Duration : Period :
BioNTech SE Technical Analysis Chart | BNTX | US09075V1026 | MarketScreener
Technical analysis trends BIONTECH SE
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 15
Last Close Price 268,58 €
Average target price 261,80 €
Spread / Average Target -2,53%
EPS Revisions
Managers and Directors
Ugur Sahin Chief Executive Officer
Jens Holstein Chief Financial Officer
Helmut Jeggle Chairman-Supervisory Board
Özlem Türeci Chief Medical Officer
Sierk Pötting Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
BIONTECH SE243.27%73 106
GILEAD SCIENCES, INC.19.55%87 368
REGENERON PHARMACEUTICALS31.46%66 402
WUXI APPTEC CO., LTD.21.75%63 075
VERTEX PHARMACEUTICALS-13.17%52 178
BEIGENE, LTD.22.78%32 604